Oct. 2, 2025

The Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) Imaging Network, managed by the ACR Center for Research and Innovation, offers participating imaging facilities exclusive access to discounted FDA-cleared AI tools and data visualization resources— to enhance Alzheimer’s imaging workflows and patient safety.

With 41 imaging facilities already participating, another 72 in start-up, and 3,184 patients enrolled from 115 referring dementia practices nationwide, ALZ-NET supports real-world evidence generation to inform FDA safety assessments and clinical guidelines – including appropriate PET use and MR safety.

Imaging facilities are invited to contribute longitudinal brain imaging data from patients receiving FDA-approved Alzheimer’s treatments.

Join the ALZ-NET Interest List today.

Related ACR News

  • Federal Government Shutdown: Key Updates

    Key information and resources for ACR members regarding the October 2025 U.S. federal government shutdown.

    Read more
  • CMS Appears to Lift Majority of Medicare Claims Holds

    The most recent update by CMS directs MACs to lift the hold on certain services impacted by select expired Medicare legislative payment provisions.

    Read more
  • Urge Your Representative to Cosponsor ROOT Act Today

    ACR urges support for H.R. 5737, the ROOT Act, to fix CMS imaging rules and save Medicare billions. Contact your rep to cosponsor today.

    Read more